TABLE 90-26
| Table 90-26. Single-Agent Activity in Recurrent Head and Neck Cancer | |
| Agent | Response (%) |
| Methotrexate | 31 |
| Bleomycin | 21 |
| Cisplatin | 28 |
| Carboplatin | 26 |
| 5-Fluorouracil | 15 |
| Paclitaxel | 38 |
| Docetaxel | 38 |
| Ifosfamide | 26 |
| Table 90-26. Single-Agent Activity in Recurrent Head and Neck Cancer | |
| Agent | Response (%) |
| Methotrexate | 31 |
| Bleomycin | 21 |
| Cisplatin | 28 |
| Carboplatin | 26 |
| 5-Fluorouracil | 15 |
| Paclitaxel | 38 |
| Docetaxel | 38 |
| Ifosfamide | 26 |